Invention Grant
- Patent Title: Binding agents binding to PD-L1 and CD137 and use thereof
-
Application No.: US16779011Application Date: 2020-01-31
-
Publication No.: US10968280B2Publication Date: 2021-04-06
- Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Ugur Sahin , Friederike Gieseke , Alexander Muik , Christian Grunwitz
- Applicant: GENMAB A/S , BIONTECH SE
- Applicant Address: DK Copenhagen; DE Mainz
- Assignee: GENMAB A/S,BIONTECH SE
- Current Assignee: GENMAB A/S,BIONTECH SE
- Current Assignee Address: DK Copenhagen; DE Mainz
- Agency: Lathrop GPM LLP
- Agent James H. Velema, Esq.; James V. DeGiulio, Esq.
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention relates to novel binding agents and their use in medicine. In particular, the invention relates to binding agents such as bispecific antibodies binding human PD-L1 and binding human CD137. The invention furthermore relates to uses of the antibodies of the invention and to methods, nucleic acid constructs and host cells for producing antibodies of the invention.
Public/Granted literature
- US20200165349A1 BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF Public/Granted day:2020-05-28
Information query
